C-Reactive Protein and Risk of Cardiovascular Events and Mortality in Patients with Various Cardiovascular Disease Locations-Reference-Cited by-同舟云学术

C-Reactive Protein and Risk of Cardiovascular Events and Mortality in Patients with Various Cardiovascular Disease Locations

Published:2023-06 Issue: Volume:197 Page:13-23
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Burger Pascal M.,Pradhan Aruna D.,Dorresteijn Jannick A.N.,Koudstaal Stefan,Teraa Martin,de Borst Gert J.,van der Meer Manon G.,Mosterd Arend,Ridker Paul M.,Visseren Frank L.J.^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice;Visseren;Eur Heart J,2021

2. Inflammation, immunity, and infection in atherothrombosis: JACC review topic of the week;Libby;J Am Coll Cardiol,2018

3. From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection;Ridker;Circ Res,2016

4. Tracking of high-sensitivity C-reactive protein after an initially elevated concentration: the JUPITER study;Glynn;Clin Chem,2009

5. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis;Kaptoge;Lancet,2010

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The rs7552841 polymorphism of protein convertase subtilisin/kexin type 9 is associated with cardiac tissue damage biomarkers and lipid profile in Tunisian patients with coronary artery disease;Gene Reports;2024-12

2. Causal relationship between C-reactive protein and ischemic stroke caused by atherosclerosis: A Mendelian randomization study;Journal of Stroke and Cerebrovascular Diseases;2024-09

3. Systemic inflammation and health outcomes in patients receiving treatment for atherosclerotic cardiovascular disease;European Heart Journal;2024-08-30

4. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases;European Heart Journal;2024-08-30

5. Inflammation: Is It a Healer, Confounder, or a Promoter of Cardiometabolic Risks?;Biomolecules;2024-08-06